806 related articles for article (PubMed ID: 12364373)
1. Tularemia.
Ellis J; Oyston PC; Green M; Titball RW
Clin Microbiol Rev; 2002 Oct; 15(4):631-46. PubMed ID: 12364373
[TBL] [Abstract][Full Text] [Related]
2. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
Rockx-Brouwer D; Chong A; Wehrly TD; Child R; Crane DD; Celli J; Bosio CM
PLoS One; 2012; 7(5):e37752. PubMed ID: 22662210
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
4. [Francisella tularensis and tularemia in Turkey].
Gürcan S
Mikrobiyol Bul; 2007 Oct; 41(4):621-36. PubMed ID: 18173084
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
6. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
7. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
8. Francisella tularensis as a potential agent of bioterrorism?
Maurin M
Expert Rev Anti Infect Ther; 2015 Feb; 13(2):141-4. PubMed ID: 25413334
[TBL] [Abstract][Full Text] [Related]
9. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
11. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.
Alqahtani M; Ma Z; Fantone K; Malik M; Bakshi CS
Infect Immun; 2021 Jun; 89(7):e0013421. PubMed ID: 33875472
[TBL] [Abstract][Full Text] [Related]
12. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
13. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
[TBL] [Abstract][Full Text] [Related]
14. Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.
De Pascalis R; Chou AY; Bosio CM; Huang CY; Follmann DA; Elkins KL
PLoS Pathog; 2012 Jan; 8(1):e1002494. PubMed ID: 22275868
[TBL] [Abstract][Full Text] [Related]
15. Rationally designed tularemia vaccines.
Mann BJ; Ark NM
Expert Rev Vaccines; 2009 Jul; 8(7):877-85. PubMed ID: 19538114
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
[TBL] [Abstract][Full Text] [Related]
17. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
18. [A water-borne tularemia outbreak caused by Francisella tularensis subspecies holarctica in Central Anatolia region].
Ulu Kılıç A; Kılıç S; Sencan I; Ciçek Şentürk G; Gürbüz Y; Tütüncü EE; Celebi B; Kıcıman Ö; Ergönül Ö
Mikrobiyol Bul; 2011 Apr; 45(2):234-47. PubMed ID: 21644066
[TBL] [Abstract][Full Text] [Related]
19. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
20. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
